In an unusual move, the U.S. Department of Justice and U.S. Patent and Trademark Office submitted a “Statement of Interest” this week in...

High-volume patent monetization entities have long focused on targets in the information technology and software sectors. But that trend...

Recent tariff increases are not only disrupting beauty brands’ supply chains and pricing strategies—they're also amplifying legal risks...

With the U.S. industries looking to focus shifting back manufacturing onshore, thinking about holistic IP strategies to protect such...

A major Federal Circuit ruling just sent a clear message to AI-driven healthtech companies: AI alone won’t get you a patent. In AliveCor,...

In Actavis v. U.S., a case at the intersection of tax law and patent law, the Federal Circuit held that generic drug companies’...

On February 28, 2025, the United States Patent and Trademark Office (USPTO) rescinded a June 2022 memorandum clarifying when the Patent...

Underscoring the exceptional value of a firm that’s purpose-built for tech and life sciences, Law360 named Fenwick a 2024 Practice Group...

Charlotte Tilbury is responding to the growing trend of beauty copycats, or dupes, with a sharp focus on marketing.  Last month,...

U.S. Patent and Trademark Office Director Kathi Vidal announced her departure from the agency to return to the private sector, a move...

The U.S. Patent and Trademark Office director, Kathi Vidal, released a final rule on Director Review effective October 31, which expands...

The United States Patent and Trademark Office (USPTO) has announced new rules governing amendment practice in trial proceedings under the...